Sensitive bromatometric assay methods for finasteride in pharmaceuticals
Main Article Content
Abstract
Three sensitive spectrophotometric methods are presented for the determination of finas-
teride in bulk and in tablets. The methods rely on the use of bromate-bromide reagent and three dyes
namely, methyl orange, indigocarmine and thymol blue as reagents. They involve the addition of a
measured excess of bromate-bromide reagent to finasteride in acid medium, and after the bromination
reaction is judged to be complete, the unreacted bromine is determined by reacting with a fixed amount
of either methylorange and measuring the absorbance at 520 nm (method A) or indigocarmine and
measuring the absorbance at 610 nm (method B) or thymol blue and measuring the absorbance at 550
nm (method C). In all the methods, the amount of insitu generated bromine reacted corresponds to the
amount of finasteride. The absorbance measured at the respective wavelength is found increase linear-
ly with the concentration of finasteride. Beer’s law is obeyed in the ranges 0.25- 2.0, 0.5-6.0 and 1-12
μg mL -1 for method A, method B and method C, respectively.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
The corresponding author transfers the copyright of the submitted manuscript and all its versions to Eclet. Quim., after having the consent of all authors, which ceases if the manuscript is rejected or withdrawn during the review process.
When a published manuscript in EQJ is also published in other journal, it will be immediately withdrawn from EQ and the authors informed of the Editor decision.
Self-archive to institutional, thematic repositories or personal webpage is permitted just after publication. The articles published by Eclet. Quim. are licensed under the Creative Commons Attribution 4.0 International License.
References
The Merck Index, 12 th Edn., Merck and Co. Inc, White
House Station. N J, 691, (1994).
Current Index of Medical Specialities (CIMS), Updated
Prescriber’s Hand Book, July-October 2005, PP.288,
CMPMedia India Pvt. Ltd., Bangalore, India.
G. Carlucci, P. Mazzeo, J. Chromatogr.-B: Biomed. Appl.
(1997) 245.
B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng.,
Anal. Chem. 70 (1998) 882.
T. Takano, S. Hata, J. Chromatogr. B: Biomed. Appl. 676
(1996) 141.
M.L. Constanzer, C.M. Chavez, B.K. Matuszewski, J.
Chromatogr. B: Biomed. Appl. 658 (1994) 281.
Yuquin, Y. Yang, L. Huichen, Yaowu Fenxi Zazhi 25 (2005)
X. Yuquing, L.Yanyan, Zhongguo Yaoke Daxue Xuebao 35
(2004) 187.
Zhiyong, C. Xiaoyan, Z.Yifan, Z. Dafang, Zhongguo
Linchuang Yaolixue Zazhi 19 (2003) 196.
L. Xiangyang, D, Li, L. Limin, Yaoxue Xuebao, 38 (2003)
P. Ptacek, J. Macek, J. Klima, J. Chromatogr, B: Biomed.
Sci. Appl., 738 (2000) 305.
L. Xiyang, C. Yifeng, C. Wansheng, Z. Bin, Z. Dong
Liang, Yaowu Fenxi Zazhi, 23 (2003) 46.
X. Mufeng, Zhongguo Yiyao Gongye Zazhi, 33 (2002)
M. F. Vitate, V.L. Perez, M. L. Palacios, M. T. Pizzorno, J.
Liq. Chromatogr. Relat. Technol., 25 (2002) 3167.
L. Xin-yuan, S. Yu-xin, Hebei Gongue Daxue Xuebao, 30
(2001) 66.
D. Hulya, C. Aysen, S. Serap, Anal. Chimica Acta, 557(1-
(2006) 252.
Z. Li, L. Luosheng, L. Fengli, Yaowu Fenxi Zazhi, 22
(2002) 456.
H. Rongfeng, F. Zhiying, W. Jian, S. Song, Zhongguo
Yiyuan Yaoxue, 22 (2002) 287.
A. A. Syed, M. K. Amshumali, J. Pharm. Biomed. Anal.,
(2001) 1015.
K. Ilango, P. Valentina, K.S.Lakshmi, Indian Drugs, 40
(2003) 122.
S. N. Meyyanathan, G.V.S. Ramasarma, B. Suresh, J.
Planar Chromatogr-Mod. TLC., 14 (2001) 188.
J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,
J. Pharm. Biomed. Anal., 9 (1991) 303.
S.M. Amer, Farmaco, 58 (2003) 159.
Martindale, The Extrapharmacopoeia, 30th Edn; The
pharmaceutical Press London. (1994) 691
The United States of Pharmacopeia. United States
Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.
K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.
Sci., 64, (2002).174.
K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)
K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29
(2003) 25.
Planar Chromatogr-Mod. TLC., 14 (2001) 188.
J.A. Ryan, S.V. Compton, M.A. Brooks, D.A.C.Compton,
J. Pharm. Biomed. Anal., 9 (1991) 303.
S.M. Amer, Farmaco, 58 (2003) 159.
Martindale, The Extrapharmacopoeia, 30th Edn; The
pharmaceutical Press London. (1994) 691
The United States of Pharmacopeia. United States
Pharamcopoeial Convention Inc., Rockville. 29 (2005) 907.
K. Ilango, P. Valentina, K.S. Lakshmi; Indian J. Pharm.
Sci., 64, (2002).174.
K. Basavaiah, H.C. Prameela, Science Asia, 29 (2003)
K. Basavaiah, H.C. Prameela, Anal. Bioanal.Chem., 29
(2003) 25.
K. Basavaiah, U. Chadrashekar, Acta Ciencia Indica
Chem., 29 (2003) 25.
. K. Basavaiah, P. Nagegowda, IL Farmaco, 59 (2004) 147.
. K. Basavaiah, P. Nagegowda, Oxid. Commun., 27 (2004)
. K. Basavaiah, H.C. Prameela, Indian J. Pharm. Sci., 67
(2004) 883.
. K. Basavaiah, Indian J. Chem. Technol., 12 (2005) 149.
. K. Basavaiah, P. Nagegowda, J. Braz. Chem. Soc., 16
(2005) 821.
. K. Basavaiah, B.C. Somashekar, Indian J. Chem.
Technol., 12 (2006) 316.
. Text on Validation of Analytical Procedures, ICH
Harmonized Tripartite Guideline,6. (1994).